18F-Florzolotau PET Imaging of Abnormal tau Protein Deposition in Alzheimer's Disease
10.3969/j.issn.1005-5185.2024.05.003
- VernacularTitle:基于18F-Florzolotau PET显像评估阿尔茨海默病脑内tau蛋白异常沉积
- Author:
Fangyang JIAO
1
;
Jiaying LU
;
Ming LI
;
Qi HUANG
;
Weiqi BAO
;
Zhengwei ZHANG
;
Zizhao JU
;
Qianhua ZHAO
;
Yihui GUAN
;
Chuantao ZUO
;
Huiwei ZHANG
Author Information
1. 复旦大学附属华山医院核医学/PET中心,上海 200235
- Keywords:
Alzheimer's disease;
Mild cognitive impairment;
tau protein;
Positron emission tomography
- From:
Chinese Journal of Medical Imaging
2024;32(5):426-430,438
- CountryChina
- Language:Chinese
-
Abstract:
Purpose To explore the value of the new generation tau PET tracer 18F-Florzolotau in Alzheimer's disease(AD)at different stages.Materials and Methods Twenty-five MCI patients and sixty-one AD patients with positive β-amyloid status in Huashan Hospital,Fudan University from February 2020 to January 2022 were retrospectively enrolled with 18F-Florzolotau PET imaging and demographic and clinical data.The pre-processed PET images were analyzed by SPM two-sample t-test between MCI and AD groups,and the standardized uptake value ratios(SUVR)were extracted from the region of interest defined by SPM analysis(P＜0.001);scaled subprofile model/principal component analysis was used to construct the different tau related patterns(MCItauRP,ADtauRP)and calculate the corresponding expression values.The classification efficiency of SUVR and MCItauRP,ADtauRP expression values was evaluated by receiver operating characteristic curve.Results Compared with MCI patients,tau protein deposition of AD patients was increased mainly in the bilateral temporal,occipital lobe(P＜0.001),and the SUVR of these brain region in the AD group was higher than that in the MCI group(Z=-3.164,P＜0.00l);the expression values of MCItauRP and ADtauRP were significantly different between the AD group and MCI group(t=3.72,Z=-3.51;both P＜0.001),and these expression values of AD patients were higher than those in the MCI group;the accuracy of tauRP expression values and SUVR for the differentiation between the AD and MCI group were 61.63％,65.12％and 65.12％,respectively;the sensitivity was 88.00％,96.00％and 100.00％,respectively;the specificity was 50.82％,52.46％and 50.82％,respectively.Conclusion The new tau PET can identify and distinguish the differences in tau protein deposition between AD and MCI patients.However,the classification and diagnosis efficiency is not high.In the future,it is necessary to find a more ideal analysis method.
